N-[3-[4-(cyclohexa-1,5-diene-1-carbonylamino)phenyl]-1-methylpyrazol-5-yl]-2-methoxybenzamide
C25H24N4O3 — CID 170596340
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[4-(cyclohexa-1,5-diene-1-carbonylamino)phenyl]-1-methylpyrazol-5-yl]-2-methoxybenzamide
N-[3-[4-(cyclohexa-1,5-diene-1-carbonylamino)phenyl]-1-methylpyrazol-5-yl]-2-methoxybenzamide (PubChem CID 170596340) has the molecular formula C25H24N4O3 and a molecular weight of 428.49 g/mol. Its IUPAC name is N-[3-[4-(cyclohexa-1,5-diene-1-carbonylamino)phenyl]-1-methylpyrazol-5-yl]-2-methoxybenzamide.
Molecular Properties
| Compound Name | N-[3-[4-(cyclohexa-1,5-diene-1-carbonylamino)phenyl]-1-methylpyrazol-5-yl]-2-methoxybenzamide |
|---|---|
| PubChem CID | 170596340 |
| Molecular Formula | C25H24N4O3 |
| Molecular Weight | 428.49 g/mol |
| Exact Mass | 428.18 |
| IUPAC Name | N-[3-[4-(cyclohexa-1,5-diene-1-carbonylamino)phenyl]-1-methylpyrazol-5-yl]-2-methoxybenzamide |
| SMILES | COc1ccccc1C(=O)Nc1cc(-c2ccc(NC(=O)C3=CCCC=C3)cc2)nn1C |
| InChI | InChI=1S/C25H24N4O3/c1-29-23(27-25(31)20-10-6-7-11-22(20)32-2)16-21(28-29)17-12-14-19(15-13-17)26-24(30)18-8-4-3-5-9-18/h4,6-16H,3,5H2,1-2H3,(H,26,30)(H,27,31) |
| InChIKey | TVCZBIOUOYCYCL-UHFFFAOYSA-N |
| XLogP | 4.56 |
| TPSA | 85.25 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.49 |
| LogP ≤ 5 | 4.56 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170596340 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.